Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SB2G
|
|||
| Former ID |
DIB003594
|
|||
| Drug Name |
EP-1300
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 1 | [1] | |
| Company |
Vaxonco; national institute of allergy and infectious diseases
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01169077) EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.